Replies to post #388459 on Elite Pharmaceuticals Inc (ELTP)

[JamesF1]

I’ll be happy to see an approval of the dopamine agonist… but until it’s approved it is not a done deal. As we all know, CRL’s happen. My bet is it’s approved….. but it is not a sure thing.

[JamesF1]

Whether it’s Mirapex or Requip, it’s a market without a lot of competition. Elite, if approved, will take market share IMHO.